Ultrasonography in diagnosing colorectal cancers in patients presenting with abdominal distension

Chen, Shyr‐Chyr; Yen, Zui-Shen; Wang, Hsiu-Po; Lee, Chien‐Chang; Hsu, Chao-Ming; Chen, Wen‐Jone; Hsu, Chao Chin; Lai, Hung-Wen; Lin, Fang‐Yue; Chen, Wei-Jao

doi:10.5694/j.1326-5377.2006.tb00415.x

Cited by 3 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The results are consistent with those of Chen et al [14] who found that ultrasonography was 92.8% sensitive, 98.8% specific, 94.7 percent positive predictive, and 98.0 percent negative predictive.…”

Section: Discussionsupporting

confidence: 92%

Evaluation of Colon Cancer by Bowel Ultrasound Compared to Colonoscopy

Mahmoud,

El shafei,

Hieza

et al. 2024

International Journal of Medical Arts

View full text Add to dashboard Cite

Article informationBackground: Multiple studies have demonstrated that abdominal ultrasonography is useful for the diagnosis of colorectal cancer [CRC]. However, controversy still exists. The aim of the work:The purpose of the study is to assess the efficacy of bowel ultrasonography in detecting colon malignancies and how it compares to colonoscopy in terms of accuracy. Patients and Methods:This cross-sectional study included 50 adults referred to the endoscopy unit at Al-Azhar University Hospital [Damietta] for suspected colon cancer. All patients underwent ultrasonography before colonoscopy. Results of the ultrasound and colonoscopy were then compared.Results: Of the 36 cases diagnosed by US as colon cancer, colonoscopy confirmed 32 as positive. Of the 14 cases diagnosed by US as negative, colonoscopy confirmed 11.Comparing US findings to histopathology, of the 36 USpositive cases, histopathology confirmed 30; of the 14 USnegative cases, histopathology confirmed 12. The sensitivity, specificity, positive predictive value, and negative predictive value of US for CRC diagnosis compared to colonoscopy were 91.4%, 73.3%, 88.8%, and 78.5%, respectively. Conclusion:A bowel ultrasonography scan can safely and noninvasively detect colorectal cancer.

show abstract

Section: Discussionsupporting

confidence: 92%

Evaluation of Colon Cancer by Bowel Ultrasound Compared to Colonoscopy

Mahmoud,

El shafei,

Hieza

et al. 2024

International Journal of Medical Arts

View full text Add to dashboard Cite

show abstract

“…W nomenklaturze angloamerykańskiej określany jako "target-sign" lub "pseudo-kidney-sign". Obraz raka jelita grubego w ultrasonografii to ubogoechowe pogrubienie ściany jelita z bogatoechowym centrum [3,4]. Guzy stromalne z reguły są hipoechogeniczne w badaniu ultrasonograficznym [5].…”

Section: Omówienieunclassified

Ultrasonography of abdominal cavity in the diagnostics of tumours of the large intestine – Case report

et al. 2014

View full text Add to dashboard Cite

Ultrasonography is a noninvasive, available and cheap test. It is the first step in diagnostics of the gastrointestinal tract, including tumours of the colon. The following article presents the history of a patient admitted to the Internal Clinic because of anaemia and unexplained weight loss. In ultrasonography, thickened wall of large intestine and pathological lymphatical nodule were found. These abnormalities were verify by colonoscopy. In the histopathological examination adenocarcinoma was recognize. The aim of this article is to draw attention to the usefulness of the ultrasound test in diagnostic tumours of the colon.

show abstract

“…The incidence of colon cancer is increased in people aged 40‐50, and the ratio is 2 to 3:1 for male: female . In the middle and late stage, patients are always with characters of abdominal distension, indigestion, abdominal pain, mucus or sticky stool . Companying with tumour ulceration, blood loss and toxin absorption, patients show more serious symptoms, including anaemia, hypothermia, fatigue, weight loss and lower extremity oedema .…”

Section: Introductionmentioning

confidence: 99%

Long non‐coding RNA POU6F2‐AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR‐377/BRD4

Zhu

et al. 2020

J Cellular Molecular Medi

View full text Add to dashboard Cite

The aim of this study was to explore the molecular mechanism of lncRNA POU6F2-AS2 in proliferation and drug resistance of colon cancer. Total paired 70 colon cancer and adjacent normal tissues were collected from colon cancer patients.Colon cancer and normal colonic epithelial cells were purchased. POU6F2-AS2 was up-or down-expressed by vectors. LC50 of all cell lines before and after transfection with these plasmids was detected. qRT-PCR was used to detect the expression of POU6F2-AS2, miR-377 and BRD4 before or after transfection. In situ hybridization was also undertaken to detect the level of POU6F2-AS2. Different concentrations of 5-Fu (0, 1, 2.5, 5, 10, 20, 40 and 80 μg/mL) were used for 5-FU insensitivity assay.CCK-8 and crystal violet staining assay were used for detecting cell proliferation, and flow cytometry was used for identifying cell cycle distribution and apoptosis. In order to detect the fragmented DNA in apoptotic cells, TUNEL assay was used. RNA pull-down assay and luciferase reporter assay were used to verify the binding site.Rescue assay confirmed the subtractive effect of miR-377 inhibitors. POU6F2-AS2 was highly expressed in colon cancer, which was associated with clinical pathology. Up-regulated POU6F2-AS2 promoted cell proliferation and cell cycle of colon cancer cells. Overexpression of POU6F2-AS2 inhibited the expression of miR-377 and then up-regulated the expression of BRD4. Up-regulated BRD4 ultimately promoted cell proliferation and cell survival Down-regulated POU6F2-AS2 showed enhanced sensitivity of 5-FU. POU6F2-AS2 promoted cell proliferation and drug resistance in colon cancer by regulating miR-377/BRD4 gene. K E Y W O R D S cell proliferation, colon cancer, drug resistance, LncRNA POU6F2-AS2, miR-377/BRD4 | 4137 XU et al. | INTRODUC TI ONColon cancer is the third gastrointestinal tumour that occurs at the junction of the rectum and the sigmoid colon. 1 The incidence of colon cancer is increased in people aged 40-50, and the ratio is 2 to 3:1 for male: female. 2 In the middle and late stage, patients are always with characters of abdominal distension, indigestion, abdominal pain, mucus or sticky stool. 3 Companying with tumour ulceration, blood loss and toxin absorption, patients show more serious symptoms, including anaemia, hypothermia, fatigue, weight loss and lower extremity oedema. 4 Colon cancer in early stage can be cured by endoscopic minimally invasive treatment, while for middle or late stage, the main treatment method is surgery. 5 Chemotherapy, immunotherapy, traditional Chinese medicine and other supportive treatments are supplement to improve the sur-Highlights 1. LncRNA POU6F2-AS2 is highly expressed in colon cancer, which is associated with clinical pathology. 2. Overexpression of lncRNA POU6F2-AS2 promotes cell proliferation and cell cycle of colon cancer cells. 3. POU6F2-AS2 inhibits the expression of miR-377 and then up-regulates the BRD4 expression. 4. Up-regulated BRD4 ultimately promotes cell prolifera-How to cite this article: Xu G, Zhu H, Xu J, et al. Lo...

show abstract

Ultrasonography in diagnosing colorectal cancers in patients presenting with abdominal distension

Cited by 3 publications

References 10 publications

Evaluation of Colon Cancer by Bowel Ultrasound Compared to Colonoscopy

Evaluation of Colon Cancer by Bowel Ultrasound Compared to Colonoscopy

Ultrasonography of abdominal cavity in the diagnostics of tumours of the large intestine – Case report

Long non‐coding RNA POU6F2‐AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR‐377/BRD4

Contact Info

Product

Resources

About